H7N9 VLP vaccine: Phase I started

Novavax began a single-blind, placebo-controlled Phase I trial evaluating 6 dose levels of 2 doses of intramuscular H7N9 VLP vaccine given 21 days apart with or without an adjuvant in up to 280 adults...